Thursday, October 6, 2022 | Back issues
Courthouse News Service Courthouse News Service

Drug Merger

WILMINGTON, Del. - Inspire Pharmaceuticals is selling itself too cheaply to Merck, for $430 million or $5 a share, shareholders say in a class action.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.